封面
市場調查報告書
商品編碼
1746735

日本體外膜氧合機市場報告(按組件、模式、應用和地區)2025-2033

Japan Extracorporeal Membrane Oxygenation Machine Market Report by Component, Modality, Application, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 117 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2024年,日本體外膜氧合機 (ECMO) 市場規模達3,310萬美元。展望未來, IMARC Group預計到2033年,該市場規模將達到5,010萬美元,2025-2033年期間的複合年成長率 (CAGR) 為4.7%。持續的研發投入推動了更先進的ECMO設備的發展,這些設備功能和性能均有所提升,包括更小巧、更便攜的設備以及更好的生物相容性,這些都推動著市場的發展。

體外膜氧合機 (ECMO) 是一種用於為嚴重呼吸衰竭或心臟衰竭患者提供臨時支援的救命醫療設備。它充當體外人工肺和/或人工心臟,從患者體內抽取血液,進行氧合,去除二氧化碳,然後將其輸回體內,使患者自身的器官得到休息和修復。 ECMO 由多個部件組成,包括幫浦、氧合器和導管。幫浦維持血流,氧合器補充氧氣並去除二氧化碳。 ECMO 可用於多種疾病,例如急性呼吸窘迫症候群 (ARDS)、心臟衰竭或複雜的心臟手術。它通常是常規治療失敗後的最後手段,為復健或移植提供過渡。 ECMO 需要專業的醫療團隊進行管理和監控。

日本體外膜氧合機(ECMO)市場趨勢:

近年來,日本體外膜氧合機 (ECMO) 市場經歷了顯著成長,這得益於幾個關鍵促進因素。首先,呼吸系統疾病(例如急性呼吸窘迫症候群 (ARDS) 和心因性休克)的盛行率不斷上升,顯著增加了對 ECMO 的需求。此外,日本人口老化導致慢性病發病率上升,進一步推動了 ECMO 市場的發展。此外,ECMO 技術的進步,包括更緊湊、更易於使用的設備的開發,使得 ECMO 治療在更廣泛的醫療環境中更容易獲得和可行。這些創新有助於擴大市場覆蓋範圍。此外,ECMO 作為重症患者救命干預措施的重要性日益增加,這導致需求激增,並推動了對 ECMO 基礎設施的大量投資。總而言之,疾病盛行率的上升、技術進步以及人們對 ECMO 在重症監護場景中有效性的認知不斷提高,這些因素共同推動了預測期內日本 ECMO 市場的發展。

日本體外膜氧合機(ECMO)市場細分:

組件洞察:

  • 氧合器
  • 套管
  • 配件
  • 控制器
  • 泵浦

模態洞察:

  • 靜脈動脈ECMO
  • 靜脈ECMO
  • 動靜脈ECMO

應用程式洞察:

  • 心臟應用
  • 呼吸應用
  • 體外心肺復甦

競爭格局:

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外,報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題:

  • 日本體外膜氧合機(ECMO)市場迄今表現如何,未來幾年將如何表現?
  • COVID-19 對日本體外膜氧合機 (ECMO) 市場有何影響?
  • 日本體外膜氧合機(ECMO)市場依組件分類的分佈如何?
  • 日本體外膜氧合機(ECMO)市場依模式分類的分佈如何?
  • 日本體外膜氧合機(ECMO)市場根據應用如何分佈?
  • 日本體外膜氧合機(ECMO)市場的價值鏈分為哪些階段?
  • 日本體外膜氧合機(ECMO)的關鍵促進因素和挑戰是什麼?
  • 日本體外膜氧合機(ECMO)市場的結構是怎麼樣的?主要參與者有哪些?
  • 日本體外膜氧合機(ECMO)市場的競爭程度如何?

本報告回答的關鍵問題:

  • 日本體外膜氧合機(ECMO)市場迄今表現如何,未來幾年將如何表現?
  • COVID-19 對日本體外膜氧合機 (ECMO) 市場有何影響?
  • 日本體外膜氧合機(ECMO)市場依組件分類的分佈如何?
  • 日本體外膜氧合機(ECMO)市場依模式分類的分佈如何?
  • 日本體外膜氧合機(ECMO)市場根據應用如何分佈?
  • 日本體外膜氧合機(ECMO)市場的價值鏈分為哪些階段?
  • 日本體外膜氧合機(ECMO)的關鍵促進因素和挑戰是什麼?
  • 日本體外膜氧合機(ECMO)市場的結構是怎麼樣的?主要參與者有哪些?
  • 日本體外膜氧合機(ECMO)市場的競爭程度如何?

目錄

第1章:前言

第2章:範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章:執行摘要

第4章:日本體外膜氧合機(ECMO)市場-簡介

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭情報

第5章:日本體外膜氧合機(ECMO)市場格局

  • 歷史與當前市場趨勢(2019-2024)
  • 市場預測(2025-2033)

第6章:日本體外膜氧合機(ECMO)市場-細分:依組件

  • 氧合器
    • 概述
  • 套管
    • 概述
  • 配件
    • 概述
  • 控制器
    • 概述
  • 泵浦
    • 概述

第7章:日本體外膜氧合機(ECMO)市場-細分:依設備類型

  • 靜脈動脈ECMO
    • 概述
  • 靜脈ECMO
    • 概述
  • 動靜脈ECMO
    • 概述

第 8 章:日本體外膜氧合機 (ECMO) 市場 - 細分:按應用

  • 心臟應用
    • 概述
  • 呼吸應用
    • 概述
  • 體外心肺復甦
    • 概述

第9章:日本體外膜氧合機(ECMO)市場-競爭格局

  • 概述
  • 市場結構
  • 市場參與者定位
  • 最佳獲勝策略
  • 競爭儀錶板
  • 公司評估象限

第10章:關鍵參與者簡介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章:日本體外膜氧合機 (ECMO) 市場 - 產業分析

  • 促進因素、限制因素和機遇
    • 概述
    • 驅動程式
    • 限制
    • 機會
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅
  • 價值鏈分析

第 12 章:附錄

簡介目錄
Product Code: SR112025A20818

Japan extracorporeal membrane oxygenation machine (ECMO) market size reached USD 33.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 50.1 Million by 2033, exhibiting a growth rate (CAGR) of 4.7% during 2025-2033. The ongoing R&D efforts, which have led to the development of more advanced ECMO machines with improved features and capabilities, including smaller, more portable devices and better biocompatibility, is driving the market.

An extracorporeal membrane oxygenation machine (ECMO) is a life-saving medical device used to provide temporary support to patients with severe respiratory or cardiac failure. It functions as an external artificial lung and/or heart by drawing blood from the patient, oxygenating it, removing carbon dioxide, and then returning it to the body, allowing the patient's own organs to rest and heal. ECMO consists of several components, including a pump, oxygenator, and tubing. The pump maintains blood flow while the oxygenator adds oxygen and removes carbon dioxide. ECMO can be used for various conditions, such as acute respiratory distress syndrome (ARDS), heart failure, or during complex cardiac surgeries. It is typically employed as a last resort when conventional treatments fail and provides a bridge to recovery or transplantation. ECMO requires a specialized team of healthcare professionals for its management and monitoring.

Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market Trends:

The extracorporeal membrane oxygenation machine (ECMO) market in Japan has witnessed remarkable growth in recent years, owing to several key drivers. Firstly, the increasing prevalence of respiratory and cardiac disorders, such as ARDS and cardiogenic shock, has significantly boosted the demand for ECMO machines. Additionally, the aging population in Japan has led to a higher incidence of chronic diseases, further propelling the ECMO market forward. Furthermore, advancements in ECMO technology, including the development of more compact and user-friendly devices, have made ECMO therapy more accessible and feasible for a broader range of healthcare settings. These innovations have been instrumental in expanding the market's reach. Moreover, the growing importance of ECMO as a life-saving intervention for critically ill patients is creating a surge in demand and driving substantial investments in ECMO infrastructure. In conclusion, a combination of increasing disease prevalence, technological advancements, and the heightened awareness of ECMO's effectiveness in critical care scenarios has been instrumental in steering the ECMO market in Japan during the forecast period.

Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market Segmentation:

Component Insights:

  • Oxygenators
  • Cannula
  • Accessories
  • Controllers
  • Pumps

Modality Insights:

  • Venoarterial ECMO
  • Venovenous ECMO
  • Arteriovenous ECMO

Application Insights:

  • Cardiac Applications
  • Respiratory Applications
  • Extracorporeal Cardiopulmonary Resuscitation

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan extracorporeal membrane oxygenation machine (ECMO) market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan extracorporeal membrane oxygenation machine (ECMO) market?
  • What is the breakup of the Japan extracorporeal membrane oxygenation machine (ECMO) market on the basis of component?
  • What is the breakup of the Japan extracorporeal membrane oxygenation machine (ECMO) market on the basis of modality?
  • What is the breakup of the Japan extracorporeal membrane oxygenation machine (ECMO) market on the basis of application?
  • What are the various stages in the value chain of the Japan extracorporeal membrane oxygenation machine (ECMO) market?
  • What are the key driving factors and challenges in the Japan extracorporeal membrane oxygenation machine (ECMO)?
  • What is the structure of the Japan extracorporeal membrane oxygenation machine (ECMO) market and who are the key players?
  • What is the degree of competition in the Japan extracorporeal membrane oxygenation machine (ECMO) market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market - Breakup by Component

  • 6.1 Oxygenators
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Cannula
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Accessories
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Controllers
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Pumps
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)

7 Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market - Breakup by Modality

  • 7.1 Venoarterial ECMO
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Venovenous ECMO
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Arteriovenous ECMO
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)

8 Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market - Breakup by Application

  • 8.1 Cardiac Applications
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Respiratory Applications
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Extracorporeal Cardiopulmonary Resuscitation
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)

9 Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market -Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix